Co-beneldopa (Benserazide/levodopa) Prescribing at ROTHSCHILD HOUSE GROUP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
732
Total Quantity
92.8K
NHS Cost
£6.2K
vs National Avg
+384.2%
ROTHSCHILD HOUSE GROUP prescribed 732 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £6,211 to the NHS. This is 384.2% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jun 2026
64
Jun 2026
58
Jun 2026
68
Jun 2026
63
Jun 2026
70
Jun 2026
61
Jun 2026
66
Jun 2026
46
Jun 2026
60
Jun 2026
62
Jun 2026
59
Jun 2026
55
Prescribing Details
| Total Items | 732 |
|---|---|
| Total Quantity | 92,800 |
| Total NHS Cost | £6,211 |
| Presentations | 12 different forms |
| vs National Average | +384.2% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 732 items |
|---|---|
| National average per practice | 151 items |
| Difference | +384.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.